ID   NCC-UPS3-C1
AC   CVCL_B3RN
DR   Wikidata; Q110433091
RX   PubMed=34665443;
WW   https://en.cellline.jp/product/ncc-ups3-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 61.6 hours (PubMed=34665443).
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Unspecified (PubMed=34665443).
CC   Sequence variation: Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Unspecified (PubMed=34665443).
CC   Omics: SNP array analysis.
CC   Derived from site: Metastatic; Left buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=34665443
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D21S11: 29,31
ST   D5S818: 11,12,13
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 17,20,21,22
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
RX   PubMed=34665443; DOI=10.1007/s13577-021-00633-w;
RA   Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Akiyama T.,
RA   Sugaya J., Nakatani F., Kojima N., Yoshida A., Ohtori S., Kawai A.,
RA   Kondo T.;
RT   "Establishment and characterization of NCC-UPS3-C1: a novel
RT   patient-derived cell line of undifferentiated pleomorphic sarcoma.";
RL   Hum. Cell 35:384-391(2022).
//